SHANGHAI FUSTAR PHARMACEUTICALS (GROUP) CO., LTD. (“FUSTAR PHARMACEUTICALS”) WILL HOLD A BOARD MEETING ON MONDAY, APRIL 29, 2024, AT WHICH TIME THE COMPANY AND ITS SUBSIDIARIES WILL CONSIDER AND APPROVE THE FIRST QUARTERLY RESULTS FOR THE THREE MONTHS ENDED MARCH 31, 2024. The Executive Directors of Fuxing Pharmaceuticals include Mr. Wu Yifang, Mr. Wang Ke Chin, Ms. Guan Xiaofui and Mr. Wen De Yung. The Non-Executive Directors are Mr. Chan Kai Yu, Mr. Yao Fang, Mr. Xu Xiaoliang and Mr. Pan Tung Fai. The Independent Non-Executive Directors include Ms. Li Ling, Mr. Yuan-Leung, Mr. Wang Quan and Mr. Yu Zi Shan Raw. The primary purpose of the meeting is to review and release the financial results for the first quarter.

SHANGHAI FUSTAR PHARMACEUTICALS (GROUP) CO., LTD. (“FUSTAR PHARMACEUTICALS”) WILL HOLD A BOARD MEETING ON MONDAY, APRIL 29, 2024, AT WHICH TIME THE COMPANY AND ITS SUBSIDIARIES WILL CONSIDER AND APPROVE THE FIRST QUARTERLY RESULTS FOR THE THREE MONTHS ENDED MARCH 31, 2024. The Executive Directors of Fuxing Pharmaceuticals include Mr. Wu Yifang, Mr. Wang Ke Chin, Ms. Guan Xiaofui and Mr. Wen De Yung. The Non-Executive Directors are Mr. Chan Kai Yu, Mr. Yao Fang, Mr. Xu Xiaoliang and Mr. Pan Tung Fai. The Independent Non-Executive Directors include Ms. Li Ling, Mr. Yuan-Leung, Mr. Wang Quan and Mr. Yu Zi Shan Raw. The primary purpose of the meeting is to review and release the financial results for the first quarter.